Patients with primary biliary cholangitis and moderate-to-severe pruritus who received seladelpar over 6 months experienced a ...
Recurrent primary biliary cholangitis (rPBC) occurs in a significant number of patients following liver transplantation for PBC. Various immunosuppressive therapies and ursodeoxycholic acid treatment ...
Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis. This ...
(RTTNews) - Primary Biliary Cholangitis is a rare, progressive, chronic autoimmune disease of the liver in which the small bile ducts are gradually destroyed, causing bile and other toxins to build up ...
Elafibranor, a dual peroxisome proliferator-activated receptor (PPAR) alpha and delta agonist, appears to be a safe and effective treatment of primary biliary cholangitis, according to a new clinical ...
The FDA announced it granted accelerated approval for Ocaliva for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid for adults who failed therapy with ...
A rare and chronic disorder known as primary biliary cholangitis, or PBC, impacts more women than men. There is no clear cause or cure, but detecting it early, can make a big difference.The day that ...
Inflammation and scarring of the bile ducts—also known as cholangiopathies—can stop the bile from flowing, a vital fluid that helps digest fats. When bile can’t move through these ducts, it backs up ...
—A recent study provides genetic evidence linking a higher body mass index (BMI) to an increased risk of primary biliary cholangitis and autoimmune hepatitis but a decreased risk of primary sclerosing ...
"Primary Biliary Cholangitis Clinical Trials"DelveInsight's,“Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline ...
AMSTERDAM — Patients with an incomplete response to first-line therapy for primary biliary cholangitis are significantly more likely to achieve a complete biochemical response with bezafibrate ...
The main drug used to treat the disease is ursodeoxycholic acid, or UDCA. Your doctor might also call it ursodiol. It’s a natural bile acid that helps move bile out of your liver and into your small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results